For example, some human tumors harbor both MDM2 overexpression and p53 mutations 47, and MDM2-overexpressing mice in a p53-null background exhibit an increased incidence of sarcomas relative to p53 knockout (KO) mice 48. Here, TP53 is linked to sarcoma.